Ghost Tree Capital as of June 30, 2020
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 42 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 8.9 | $34M | 300k | 111.95 | |
| Immunomedics | 5.4 | $20M | 575k | 35.44 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 5.3 | $20M | 65k | 308.35 | |
| Constellation Pharmceticls I | 5.2 | $20M | 650k | 30.05 | |
| Adverum Biotechnologies | 5.0 | $19M | 900k | 20.88 | |
| Mirati Therapeutics | 4.7 | $18M | 155k | 114.17 | |
| Iovance Biotherapeutics (IOVA) | 4.2 | $16M | 580k | 27.45 | |
| Mersana Therapeutics (MRSN) | 3.9 | $15M | 625k | 23.40 | |
| Rocket Pharmaceuticals (RCKT) | 3.6 | $14M | 650k | 20.93 | |
| Momenta Pharmaceuticals | 3.4 | $13M | 385k | 33.27 | |
| Immunovant (IMVT) | 3.4 | $13M | 525k | 24.35 | |
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 3.3 | $12M | 50k | 247.28 | |
| Trillium Therapeutics Com New | 3.3 | $12M | 1.5M | 8.09 | |
| Tg Therapeutics (TGTX) | 3.1 | $12M | 600k | 19.48 | |
| Gilead Sciences (GILD) | 3.0 | $12M | 150k | 76.96 | |
| Satsuma Pharmaceuticals Ord | 2.6 | $9.8M | 340k | 28.76 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 2.5 | $9.6M | 65k | 147.91 | |
| BioCryst Pharmaceuticals (BCRX) | 2.4 | $9.1M | 1.9M | 4.77 | |
| Aurinia Pharmaceuticals (AUPH) | 2.4 | $8.9M | 550k | 16.25 | |
| Axsome Therapeutics (AXSM) | 2.2 | $8.2M | 100k | 82.28 | |
| ACADIA Pharmaceuticals (ACAD) | 2.1 | $8.0M | 165k | 48.47 | |
| Reata Pharmaceuticals Cl A | 2.1 | $7.8M | 50k | 156.02 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 1.8 | $6.7M | 825k | 8.08 | |
| Myovant Sciences | 1.6 | $6.2M | 300k | 20.62 | |
| Agios Pharmaceuticals (AGIO) | 1.6 | $6.2M | 115k | 53.48 | |
| Wave Life Sciences SHS (WVE) | 1.5 | $5.6M | 535k | 10.41 | |
| Surface Oncology | 1.2 | $4.6M | 700k | 6.56 | |
| Iveric Bio | 1.2 | $4.6M | 900k | 5.10 | |
| Fate Therapeutics (FATE) | 1.1 | $4.3M | 125k | 34.31 | |
| Kalvista Pharmaceuticals (KALV) | 1.1 | $4.2M | 350k | 12.10 | |
| Aldeyra Therapeutics (ALDX) | 1.1 | $4.2M | 1.0M | 4.17 | |
| Xenon Pharmaceuticals (XENE) | 1.1 | $4.1M | 325k | 12.54 | |
| Arvinas Ord (ARVN) | 1.1 | $4.0M | 120k | 33.54 | |
| Homology Medicines | 0.9 | $3.6M | 235k | 15.19 | |
| Selecta Biosciences (RNAC) | 0.7 | $2.8M | 1.0M | 2.84 | |
| Syndax Pharmaceuticals (SNDX) | 0.7 | $2.7M | 185k | 14.82 | |
| Polypid SHS | 0.5 | $1.8M | 100k | 18.03 | |
| Altimmune Com New (ALT) | 0.4 | $1.6M | 150k | 10.71 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.3 | $1.3M | 50k | 25.48 | |
| Viewray (VRAYQ) | 0.2 | $672k | 300k | 2.24 | |
| Moderna (MRNA) | 0.2 | $642k | 10k | 64.20 | |
| Invesco Currencyshares Euro Euro Shs (FXE) | 0.1 | $212k | 2.0k | 106.00 |
